flunitrazepam has been researched along with scopolamine hydrobromide in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
McGeer, E; McGeer, PL | 1 |
Kangas, L; Kanto, J; Leppänen, T; Pakkanen, A | 1 |
Alkalay, D; Chapman, S; Cohen, G; Gilat, E; Rabinovitz, I; Raveh, L; Weissman, BA | 1 |
Duns, AK; Lund, C; Netland, H; Rasmussen, IA; Vallersnes, OM | 1 |
Galizio, M; Mason, M; Mathews, M; Panoz-Brown, D; Prichard, A; Soto, P | 1 |
1 trial(s) available for flunitrazepam and scopolamine hydrobromide
Article | Year |
---|---|
Comparison of old and new types of premedications.
Topics: Administration, Oral; Anti-Anxiety Agents; Flunitrazepam; Humans; Injections, Intramuscular; Morphine; Pentobarbital; Preanesthetic Medication; Scopolamine | 1982 |
6 other study(ies) available for flunitrazepam and scopolamine hydrobromide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Possible destruction of cholinoceptive neurons by overstimulation of cholinergic tracts.
Topics: Animals; Brain; Choline O-Acetyltransferase; Cholinergic Fibers; Diazepam; Epilepsy; Flunitrazepam; Glutamate Decarboxylase; Histocytochemistry; Male; Neurons; Pons; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Scopolamine; Tyrosine 3-Monooxygenase | 1986 |
The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning.
Topics: Animals; Brain; Cholinesterase Inhibitors; Cyclopentanes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Electroencephalography; Excitatory Amino Acid Antagonists; Flunitrazepam; In Vitro Techniques; Male; Mice; Mice, Inbred ICR; Parasympatholytics; Protein Binding; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Scopolamine; Seizures; Soman; Time Factors | 1999 |
Epidemic of poisoning caused by scopolamine disguised as Rohypnol tablets.
Topics: Adult; Drug Contamination; Female; Flunitrazepam; Humans; Illicit Drugs; Male; Middle Aged; Muscarinic Antagonists; Norway; Poisoning; Retrospective Studies; Scopolamine; Syndrome; Young Adult | 2009 |
Amnestic drugs in the odor span task: Effects of flunitrazepam, zolpidem and scopolamine.
Topics: Amnesia; Animals; Cholinergic Antagonists; Discrimination, Psychological; Dose-Response Relationship, Drug; Flunitrazepam; GABA Modulators; GABA-A Receptor Agonists; Male; Memory, Short-Term; Neurotransmitter Agents; Odorants; Olfactory Perception; Pyridines; Rats, Sprague-Dawley; Scopolamine; Zolpidem | 2017 |